Jonathan L. Bramson

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Canagliflozin is a novel androgen receptor pathway inhibitor for castrate-sensitive and castrate-resistant prostate cancer.

Canagliflozin is a novel androgen receptor pathway inhibitor for castrate-sensitive and castrate-resistant prostate cancer.

Journal: Cancer letters

Published: October 06, 2025

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Journal: Current oncology (Toronto, Ont.)

Published: October 02, 2025

IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy.

IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy.

Journal: Oncoimmunology

Published: September 25, 2025

HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer.

HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer.

Journal: Journal of leukocyte biology

Published: August 22, 2025

Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents.

Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents.

Journal: Vaccine

Published: July 24, 2025

Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows.

Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows.

Journal: Cell reports methods

Published: July 23, 2025

Author Correction: No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations.

Author Correction: No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations.

Journal: Nature communications

Published: June 19, 2025

Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations.

Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborations.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: March 24, 2025

Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.

Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.

Journal: Blood cancer discovery

Published: March 10, 2025

Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.

Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.

Journal: Blood cancer discovery

Published: March 10, 2025

Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies.

Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies.

Journal: Oncoimmunology

Published: February 28, 2025

A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor.

A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor.

Journal: Cancer immunology research

Published: January 20, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026